Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
about
MST1 is a multifunctional caspase-independent inhibitor of androgenic signaling.Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120The hippo signaling pathway in development and cancerA Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue SarcomasThe two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatmentHippo/YAP pathway for targeted therapyThe Hippo-YAP pathway in organ size control and tumorigenesis: an updated versionMerlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survivalThe Hippo Pathway Targets Rae1 to Regulate Mitosis and Organ Size and to Feed Back to Regulate Upstream Components Merlin, Hippo, and WartsSalvador-Warts-Hippo pathway in a developmental checkpoint monitoring helix-loop-helix proteins.Yes-associated protein 1 is activated and functions as an oncogene in meningiomas.The Hippo signaling pathway and translational opportunities for brain cancersThe Hippo signaling pathway in stem cell biology and cancerThe role of the Hippo pathway in human disease and tumorigenesisMicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo.Expression of hippo pathway in colorectal cancer.A beta-mixture model for dimensionality reduction, sample classification and analysis.Overexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression.The mitosis-to-interphase transition is coordinated by cross talk between the SIN and MOR pathways in Schizosaccharomyces pombe.Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.DNA methylation biomarkers for lung cancer.Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.Competing to coordinate cell fate decisions: the MST2-Raf-1 signaling deviceThe hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesisYAPing Hippo Forecasts a New Target for Lung Cancer Prevention and Treatment.Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancerDNA methylation: its role in cancer development and therapy.Angiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component mutationsAlveolar rhabdomyosarcoma-associated PAX3-FOXO1 promotes tumorigenesis via Hippo pathway suppression.Snapshots of a hybrid transcription factor in the Hippo pathway.Mammalian Hippo pathway: from development to cancer and beyond.Integrating developmental signals: a Hippo in the (path)way.Drosophila cancer models.Epigenetic and epigenomic mechanisms shape sarcoma and other mesenchymal tumor pathogenesis.Epithelial cell polarity, stem cells and cancer.The Hippo pathway regulates stem cell proliferation, self-renewal, and differentiationRole of Hippo signaling in cancer stem cells.One Hippo and many masters: differential regulation of the Hippo pathway in cancer.
P2860
Q24300132-24FF6E61-F18B-4816-BA31-4FF33E493101Q24321602-CCDEAD38-6BAA-4191-887D-99E746EC2C08Q24603986-C871E437-9F33-435C-BFA8-767F60C3B8A0Q26782842-B4E2A7AF-37D6-41FE-8002-79AB499E9D41Q27025661-6390C22E-5C1B-4B77-A3D2-64675D9499EFQ28088294-2F23F3D8-29E6-45A9-B7FB-6DCEAECB9432Q28281214-BBB3329E-51DF-446E-BD56-EEB39D3FCCE3Q28283076-B5E5E3EB-9479-4900-B763-F7F3750EFDCCQ28553403-60A72D55-E702-41DA-9F67-E24A9B0DFF96Q30392982-CB26899C-E6C1-4276-B868-7C4BFC97B2B2Q30394387-E2C95083-9D4D-4F92-B14A-7B813023F05DQ30395225-4B06385A-5BDB-4A83-8DE3-174C311CC90AQ30410176-DD7FE1D7-A297-441D-934C-13AB48F5EAA5Q30433413-A31DAE1C-7BCF-40FB-BB6E-16AE25F71BCAQ33555058-F4EEC519-9462-4C29-B88C-84FF5B9990DFQ33796051-17B0325D-5A83-457A-BC30-2849EA1A38F6Q33914431-4FA1D900-8B11-4B6D-9608-D44BA64F8E57Q34000446-47D46B92-5423-4999-A15D-7D671E04E210Q34110963-2399C426-7BE7-4BC0-8E91-C21D72BC9A94Q34181789-3D081AE2-D85E-419C-A74A-6FD37142A987Q34238508-BE56CD3B-8E11-4924-99BC-1900249722C1Q34268075-5F7733AC-EC63-4A25-A6E2-634164555D93Q35158033-5FD9CAB3-78B8-4456-937A-3EFA574BD83CQ35214708-1FBAF8D9-FCE6-4CDD-933A-06628FC540A8Q35688452-09D4A0D7-6343-40B1-B7E9-7330A6AE4CD9Q35818801-4A83AC13-116B-43BA-81B1-A3FF59EC03F2Q36737585-6763B950-EB0E-43BB-9FBA-7CE763B3B15CQ36818078-C964DE15-DEE7-4340-BB1C-26FBCFA7C2C4Q36986433-401663FC-E9ED-43F3-BE4F-356B9511BEE7Q37301667-1A2EB966-C081-4F49-8810-34605B6CB013Q37410567-142C8142-A897-4A6C-A385-4A5227997DE9Q37825816-028B1198-9983-46AC-B095-47030ECCC540Q37843031-4B93F772-B842-462E-8E9C-7A0C8E7E5240Q37923302-A88AEB17-5CC7-4B75-ACE6-99ABF382AC31Q37950977-A88EF8AA-B0F6-452C-BBC2-6F1A1E9C47ECQ37962606-7D3D9605-F753-4ED2-8AD9-07FE7F33BB2EQ37968480-0FEF74D1-1E76-4E94-A1D8-F007A899F322Q38006856-B3667C18-ED8D-44C4-BBB2-97F8EFB8CEA9Q38137820-CCF3FBF5-828D-4D0E-970A-B30D8D615A6BQ38238612-CBC1E7DF-F468-4C01-8DFF-8797569D1E7E
P2860
Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
@ast
Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
@en
Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
@nl
type
label
Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
@ast
Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
@en
Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
@nl
prefLabel
Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
@ast
Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
@en
Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
@nl
P2093
P356
P1476
Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
@en
P2093
Claudia Seidel
Gerd P Pfeifer
Karen Blümke
Peter Würl
Reinhard Dammann
Steffen Hauptmann
Undraga Schagdarsurengin
P304
P356
10.1002/MC.20317
P577
2007-10-01T00:00:00Z